This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tremblay, G. B.
Right arrow Articles by Giguère, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremblay, G. B.
Right arrow Articles by Giguère, V.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 1999, p. 1919-1927, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Dominant Activity of Activation Function 1 (AF-1) and Differential Stoichiometric Requirements for AF-1 and -2 in the Estrogen Receptor alpha -beta Heterodimeric Complex

Gilles B. Tremblay,1 André Tremblay,1 Fernand Labrie,2 and Vincent Giguère1,3,*

Molecular Oncology Group, McGill University Health Center,1 and Departments of Biochemistry, Medicine and Oncology, McGill University,3 Montréal, and Laboratory of Molecular Endocrinology, Laval University Medical Research Center and Laval University, Québec,2 Québec, Canada

Received 16 October 1998/Returned for modification 19 November 1998/Accepted 1 December 1998

Estrogenic responses are now known to be mediated by two forms of estrogen receptors (ER), ERalpha and ERbeta , that can function as homodimers or heterodimers. As homodimers the two have been recently shown to exhibit distinct transcriptional responses to estradiol (E2), antiestrogens, and coactivators, suggesting that the ER complexes are not functionally equivalent. However, because the three possible configurations of ER complexes all recognize the same estrogen response element, it has not been possible to evaluate the transcriptional properties of the ER heterodimer complex by transfection assays. Using ER subunits with modified DNA recognition specificity, we were able to measure the transcriptional properties of ERalpha -ERbeta heterodimers in transfected cells without interference from the two ER homodimer complexes. We first demonstrated that the individual activation function 1 (AF-1) domains act in a dominant manner within the ERalpha -ERbeta heterodimer: the mixed agonist-antagonist 4-hydroxytamoxifen acts as an agonist in a promoter- and cell context-dependent manner via the ERalpha AF-1, while activation of the complex by the mitogen-activated protein kinase (MAPK) pathway requires only the ERalpha - or ERbeta -responsive MAPK site. Using ligand-binding and AF-2-defective mutants, we further demonstrated that while the ERalpha -ERbeta heterodimer can be activated when only one E2-binding competent partner is present per dimer, two functional AF-2 domains are required for transcriptional activity. Taken together, the results of this study of a retinoid X receptor-independent heterodimer complex, the first such study, provide evidence of different stoichiometric requirements for AF-1 and -2 activity and demonstrate that AF-1 receptor-specific properties are maintained within the ERalpha -ERbeta heterodimer.

* Corresponding author. Mailing address: Molecular Oncology Group, Royal Victoria Hospital, 687 Pine Ave. West, Montréal, Québec, Canada H3A 1A1. Phone: (514) 843-1479. Fax: (514) 843-1478. E-mail: vgiguere{at}dir.molonc.mcgill.ca.

Molecular and Cellular Biology, March 1999, p. 1919-1927, Vol. 19, No. 3
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Papoutsi, Z., Zhao, C., Putnik, M., Gustafsson, J.-A., Dahlman-Wright, K. (2009). Binding of estrogen receptor {alpha}/{beta} heterodimers to chromatin in MCF-7 cells. J Mol Endocrinol 43: 65-72 [Abstract] [Full Text]  
  • Powell, E., Xu, W. (2008). Intermolecular interactions identify ligand-selective activity of estrogen receptor {alpha}/{beta} dimers. Proc. Natl. Acad. Sci. USA 105: 19012-19017 [Abstract] [Full Text]  
  • Glassberg, M. K., Elliot, S. J., Fritz, J., Catanuto, P., Potier, M., Donahue, R., Stetler-Stevenson, W., Karl, M. (2008). Activation of the Estrogen Receptor Contributes to the Progression of Pulmonary Lymphangioleiomyomatosis via Matrix Metalloproteinase-Induced Cell Invasiveness. J. Clin. Endocrinol. Metab. 93: 1625-1633 [Abstract] [Full Text]  
  • Sabo-Attwood, T., Blum, J. L, Kroll, K. J, Patel, V., Birkholz, D., Szabo, N. J, Fisher, S. Z, McKenna, R., Campbell-Thompson, M., Denslow, N. D (2007). Distinct expression and activity profiles of largemouth bass (Micropterus salmoides) estrogen receptors in response to estradiol and nonylphenol. J Mol Endocrinol 39: 223-237 [Abstract] [Full Text]  
  • Baron, S., Escande, A., Alberola, G., Bystricky, K., Balaguer, P., Richard-Foy, H. (2007). Estrogen Receptor {alpha} and the Activating Protein-1 Complex Cooperate during Insulin-like Growth Factor-I-induced Transcriptional Activation of the pS2/TFF1 Gene. J. Biol. Chem. 282: 11732-11741 [Abstract] [Full Text]  
  • Ohnemus, U., Uenalan, M., Inzunza, J., Gustafsson, J.-A., Paus, R. (2006). The Hair Follicle as an Estrogen Target and Source. Endocr. Rev. 27: 677-706 [Abstract] [Full Text]  
  • Iwasaki, T., Takeshita, A., Miyazaki, W., Chin, W. W., Koibuchi, N. (2006). The Interaction of TR{beta}1-N Terminus with Steroid Receptor Coactivator-1 (SRC-1) Serves a Full Transcriptional Activation Function of SRC-1. Endocrinology 147: 1452-1457 [Abstract] [Full Text]  
  • Bodo, C., Kudwa, A. E., Rissman, E. F. (2006). Both Estrogen Receptor-{alpha} and -{beta} Are Required for Sexual Differentiation of the Anteroventral Periventricular Area in Mice. Endocrinology 147: 415-420 [Abstract] [Full Text]  
  • Hall, J. M., McDonnell, D. P. (2005). Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting. Mol. Interv. 5: 343-357 [Abstract] [Full Text]  
  • Penot, G., Le Peron, C., Merot, Y., Grimaud-Fanouillere, E., Ferriere, F., Boujrad, N., Kah, O., Saligaut, C., Ducouret, B., Metivier, R., Flouriot, G. (2005). The Human Estrogen Receptor-{alpha} Isoform hER{alpha}46 Antagonizes the Proliferative Influence of hER{alpha}66 in MCF7 Breast Cancer Cells. Endocrinology 146: 5474-5484 [Abstract] [Full Text]  
  • Huang, J., Li, X., Maguire, C. A., Hilf, R., Bambara, R. A., Muyan, M. (2005). Binding of Estrogen Receptor {beta} to Estrogen Response Element in Situ Is Independent of Estradiol and Impaired by Its Amino Terminus. Mol. Endocrinol. 19: 2696-2712 [Abstract] [Full Text]  
  • Li, X., Huang, J., Yi, P., Bambara, R. A., Hilf, R., Muyan, M. (2004). Single-Chain Estrogen Receptors (ERs) Reveal that the ER{alpha}/{beta} Heterodimer Emulates Functions of the ER{alpha} Dimer in Genomic Estrogen Signaling Pathways. Mol. Cell. Biol. 24: 7681-7694 [Abstract] [Full Text]  
  • Merot, Y., Metivier, R., Penot, G., Manu, D., Saligaut, C., Gannon, F., Pakdel, F., Kah, O., Flouriot, G. (2004). The Relative Contribution Exerted by AF-1 and AF-2 Transactivation Functions in Estrogen Receptor {alpha} Transcriptional Activity Depends upon the Differentiation Stage of the Cell. J. Biol. Chem. 279: 26184-26191 [Abstract] [Full Text]  
  • Palmieri, C., Lam, E. W.-F., Mansi, J., MacDonald, C., Shousha, S., Madden, P., Omoto, Y., Sunters, A., Warner, M., Gustafsson, J.-A., Coombes, R. C. (2004). The Expression of ER{beta}cx in Human Breast Cancer and the Relationship to Endocrine Therapy and Survival. Clin. Cancer Res. 10: 2421-2428 [Abstract] [Full Text]  
  • Cheng, C. K., Chow, B. K. C., Leung, P. C. K. (2003). An Activator Protein 1-Like Motif Mediates 17{beta}-Estradiol Repression of Gonadotropin-Releasing Hormone Receptor Promoter via an Estrogen Receptor {alpha}-Dependent Mechanism in Ovarian and Breast Cancer Cells. Mol. Endocrinol. 17: 2613-2629 [Abstract] [Full Text]  
  • Ikeda, Y., Nagai, A., Ikeda, M.-A., Hayashi, S. (2003). Sexually Dimorphic and Estrogen-Dependent Expression of Estrogen Receptor {beta} in the Ventromedial Hypothalamus during Rat Postnatal Development. Endocrinology 144: 5098-5104 [Abstract] [Full Text]  
  • Kelley, K. M. M., Rowan, B. G., Ratnam, M. (2003). Modulation of the Folate Receptor {alpha} Gene by the Estrogen Receptor: Mechanism and Implications in Tumor Targeting. Cancer Res. 63: 2820-2828 [Abstract] [Full Text]  
  • Bai, Y., Giguere, V. (2003). Isoform-Selective Interactions between Estrogen Receptors and Steroid Receptor Coactivators Promoted by Estradiol and ErbB-2 Signaling in Living Cells. Mol. Endocrinol. 17: 589-599 [Abstract] [Full Text]  
  • Gaskell, T. L., Robinson, L. L. L., Groome, N. P., Anderson, R. A., Saunders, P. T. K. (2003). Differential Expression of Two Estrogen Receptor {beta} Isoforms in the Human Fetal Testis during the Second Trimester of Pregnancy. J. Clin. Endocrinol. Metab. 88: 424-432 [Abstract] [Full Text]  
  • Torres-Padilla, M. E., Sladek, F. M., Weiss, M. C. (2002). Developmentally Regulated N-terminal Variants of the Nuclear Receptor Hepatocyte Nuclear Factor 4alpha Mediate Multiple Interactions through Coactivator and Corepressor-Histone Deacetylase Complexes. J. Biol. Chem. 277: 44677-44687 [Abstract] [Full Text]  
  • Matsuda, K.-i., Ochiai, I., Nishi, M., Kawata, M. (2002). Colocalization and Ligand-Dependent Discrete Distribution of the Estrogen Receptor (ER){alpha} and ER{beta}. Mol. Endocrinol. 16: 2215-2230 [Abstract] [Full Text]  
  • Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H. Jr., Pestell, R. G., Kushner, P. J. (2002). Opposing Action of Estrogen Receptors alpha and beta on Cyclin D1 Gene Expression. J. Biol. Chem. 277: 24353-24360 [Abstract] [Full Text]  
  • Saunders, P. T. K., Millar, M. R., Macpherson, S., Irvine, D. S., Groome, N. P., Evans, L. R., Sharpe, R. M., Scobie, G. A. (2002). ER{beta}1 and the ER{beta}2 Splice Variant (ER{beta}cx/{beta}2) Are Expressed in Distinct Cell Populations in the Adult Human Testis. J. Clin. Endocrinol. Metab. 87: 2706-2715 [Abstract] [Full Text]  
  • Lopez, D., Sanchez, M. D., Shea-Eaton, W., McLean, M. P. (2002). Estrogen Activates the High-Density Lipoprotein Receptor Gene via Binding to Estrogen Response Elements and Interaction with Sterol Regulatory Element Binding Protein-1A. Endocrinology 143: 2155-2168 [Abstract] [Full Text]  
  • Menuet, A., Pellegrini, E., Anglade, I., Blaise, O., Laudet, V., Kah, O., Pakdel, F. (2002). Molecular Characterization of Three Estrogen Receptor Forms in Zebrafish: Binding Characteristics, Transactivation Properties, and Tissue Distributions. Biol. Reprod. 66: 1881-1892 [Abstract] [Full Text]  
  • Denger, S., Reid, G., Kos, M., Flouriot, G., Parsch, D., Brand, H., Korach, K. S., Sonntag-Buck, V., Gannon, F. (2001). ER{alpha} Gene Expression in Human Primary Osteoblasts: Evidence for the Expression of Two Receptor Proteins. Mol. Endocrinol. 15: 2064-2077 [Abstract] [Full Text]  
  • Greco, B., Allegretto, E. A., Tetel, M. J., Blaustein, J. D. (2001). Coexpression of ER{beta} with ER{alpha} and Progestin Receptor Proteins in the Female Rat Forebrain: Effects of Estradiol Treatment. Endocrinology 142: 5172-5181 [Abstract] [Full Text]  
  • Lu, D., Kiriyama, Y., Lee, K. Y., Giguere, V. (2001). Transcriptional Regulation of the Estrogen-inducible pS2 Breast Cancer Marker Gene by the ERR Family of Orphan Nuclear Receptors. Cancer Res. 61: 6755-6761 [Abstract] [Full Text]  
  • Clarke, R., Leonessa, F., Welch, J. N., Skaar, T. C. (2001). Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance. Pharmacol. Rev. 53: 25-72 [Abstract] [Full Text]  
  • Métivier, R., Petit, F. G., Valotaire, Y., Pakdel, F. (2000). Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain. Mol. Endocrinol. 14: 1849-1871 [Abstract] [Full Text]  
  • Speirs, V., Adams, I. P., Walton, D. S., Atkin, S. L. (2000). Identification of Wild-Type and Exon 5 Deletion Variants of Estrogen Receptor {beta} in Normal Human Mammary Gland. J. Clin. Endocrinol. Metab. 85: 1601-1605 [Abstract] [Full Text]  
  • Oberste-Berghaus, C., Zanger, K., Hashimoto, K., Cohen, R. N., Hollenberg, A. N., Wondisford, F. E. (2000). Thyroid Hormone-independent Interaction between the Thyroid Hormone Receptor beta 2 Amino Terminus and Coactivators. J. Biol. Chem. 275: 1787-1792 [Abstract] [Full Text]  
  • Castro, D. S., Arvidsson, M., Bolin, M. B., Perlmann, T. (1999). Activity of the Nurr1 Carboxyl-terminal Domain Depends on Cell Type and Integrity of the Activation Function 2. J. Biol. Chem. 274: 37483-37490 [Abstract] [Full Text]  
  • Webb, P., Nguyen, P., Valentine, C., Lopez, G. N., Kwok, G. R., McInerney, E., Katzenellenbogen, B. S., Enmark, E., Gustafsson, J.-A., Nilsson, S., Kushner, P. J. (1999). The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions. Mol. Endocrinol. 13: 1672-1685 [Abstract] [Full Text]  
  • Gutman, M., Couillard, S., Labrie, F., Candas, B., Labrie, C. (1999). Effects of the Antiestrogen EM-800 (SCH 57050) and Cyclophosphamide Alone and in Combination on Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice. Cancer Res. 59: 5176-5180 [Abstract] [Full Text]  
  • Jakacka, M., Ito, M., Weiss, J., Chien, P.-Y., Gehm, B. D., Jameson, J. L. (2001). Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway. J. Biol. Chem. 276: 13615-13621 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»